Medication Shortage For ADHD: Urgent FDA/DEA Action Needed, Is Cannabis An Alternative?

The shortage of stimulant-based ADHD (Attention Deficit Hyperactivity Disorder) medications like Adderall, Vyvanse and Ritalin persists, with leading drug makers unable to provide a solution. The shortage began in Fall 2022 and was exacerbated by record-high prescription rates.

Related Keywords

California ,United States ,American , ,California Institute Of Behavioral Neuroscience Psychology ,Teva Pharmaceutical Industries ,American Society Of Health ,Bloomberg ,Journal Of Psychiatric Research ,Attention Deficit Hyperactivity Disorder ,Pharmaceutical Industries ,Shortage And Urgent ,American Society ,Health System Pharmacists ,European Neuropsychopharmacology ,Psychiatric Research ,California Institute ,Behavioral Neuroscience ,